Drug-induced gynecomastia: an evidence-based review

  title={Drug-induced gynecomastia: an evidence-based review},
  author={Fnu Deepinder and G. Braunstein},
  journal={Expert Opinion on Drug Safety},
  pages={779 - 795}
  • Fnu Deepinder, G. Braunstein
  • Published 2012
  • Medicine
  • Expert Opinion on Drug Safety
  • Introduction: Drugs are estimated to cause about 10 – 25% of all cases of gynecomastia. Over the course of several decades, multiple medications have been implicated in the development of gynecomastia mostly in the form of case reports and case series. However, these reports suffer from a multitude of deficiencies, including poor quality of evidence. Areas covered: Studies were selected for this review by performing an extensive electronic and hand-search using BIOSIS, EMBASE and Medline, from… CONTINUE READING
    Anabolic steroid-induced hypogonadism: diagnosis and treatment.
    • 92
    Gynecomastia and hormones
    • 31


    Publications referenced by this paper.
    Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.
    • 834
    • PDF
    [Drug-induced gynecomastia].
    • 67
    Gynecomastia: pathomechanisms and treatment strategies.
    • 92
    Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes.
    • 539
    Gynaecomastia Associated with Proton Pump Inhibitors
    • 21